Busca avançada
Ano de início
Entree


Effect of the secretome of mesenchymal stem cells overexpressing BMP-9 on osteoblast differentiation and bone repair

Texto completo
Autor(es):
Calixto, Robson Diego ; Freitas, Gileade Pereira ; Souza, Paola Gomes ; Ramos, Jaqueline Isadora Reis ; Santos, Isabela Cristine ; de Oliveira, Fabiola Singaretti ; Almeida, Adriana Luisa Goncalves ; Rosa, Adalberto Luiz ; Beloti, Marcio Mateus
Número total de Autores: 9
Tipo de documento: Artigo Científico
Fonte: Journal of Cellular Physiology; v. N/A, p. 13-pg., 2023-09-03.
Resumo

The secretome present in the conditioned medium (CM) of mesenchymal stem cells (MSCs) is a promising tool to be used in therapies to promote bone regeneration. Considering the high osteogenic potential of the bone morphogenetic protein 9 (BMP-9), we hypothesized that the secretome of MSCs overexpressing BMP-9 (MSCsBMP-9) enhances the osteoblast differentiation of MSCs and the bone formation in calvarial defects. CM of either MSCsBMP-9 (CM-MSCsBMP-9) or MSCs without BMP-9 overexpression (CM-MSCsVPR) were obtained at different periods. As the CM-MSCsBMP-9 generated after 1 h presented the highest BMP-9 concentration, CM-MSCsBMP-9 and CM-MSCsVPR were collected at this time point and used to culture MSCs and to be injected into mouse calvarial defects. The CM-MSCsBMP-9 enhanced the osteoblast differentiation of MSC by upregulating RUNX2, alkaline phosphatase (ALP) and osteopontin protein expression, and ALP activity, compared with CM-MSCsVPR. The CM-MSCsBMP-9 also enhanced the bone repair of mouse calvarial defects, increasing bone volume, bone volume/total volume, bone surface, and trabecular number compared with untreated defects and defects treated with CM-MSCsVPR or even with MSCsBMP-9 themselves. In conclusion, the potential of the MSCBMP-9-secretome to induce osteoblast differentiation and bone formation shed lights on novel cell-free-based therapies to promote bone regeneration of challenging defects. (AU)

Processo FAPESP: 17/12622-7 - Terapia celular: potencial de células-tronco mesenquimais, VEGF-A e BMP-9 para regenerar tecido ósseo
Beneficiário:Adalberto Luiz Rosa
Modalidade de apoio: Auxílio à Pesquisa - Temático
Processo FAPESP: 20/06599-5 - Efeito do meio condicionado por células-tronco mesenquimais com superexpressão de proteína óssea morfogenética 9 na diferenciação osteoblástica e na regeneração óssea
Beneficiário:Robson Diego Calixto
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 19/01346-4 - Estudo do potencial angiogênico e para regenerar o tecido ósseo de BM-MSCs e AT-MSCs modificadas geneticamente utilizando CRISPR-Cas9 para sobre-expressar VEGF-A e BMP-9
Beneficiário:Gileade Pereira Freitas
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado